NCT06379009 Effect of Home-based Training Program for Kidney Transplant Recipients (HOMETRAIN-KTR)
| NCT ID | NCT06379009 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oslo University Hospital |
| Condition | Kidney Transplant; Complications |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-02-07 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-02-07 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Does home-based training work in kidney transplant recipients with reduced physical function? The goal of this clinical trial is to learn if home-based training works to better physical function in adult kidney transplant recipients. It will also learn about participants preoperative physical function. The main question it aim to answer is * Does home-based training improves physical function in kidney transplant recipients. * All the participants are assessed to have reduced physical function before the transplantation Participants will: * follow either a home-based training program or todays standard of physical activity after kidney transplantation * the program starts 4 weeks after the transplantation and lasts for 12 weeks. A physiotherapist will help the participants in the beginning. * the program consists of both cardio-training, strength-straining and optional activity * the training group will be followed up every week by phone. Their activity will be documented via patients logs and heart rate monitor. * the effect of the training will be evaluated one year after the transplantation
Eligibility Criteria
Inclusion Criteria: * Being 18 years old or older and going through Ktx * Scores 75 or lower at physical function at SF-36 at time of KTx * Able to perform the 6MWT * Able to speak, read and understand Norwegian or English * Being mentally and cognitively capable of participating in the intervention and responding to follow-up questionnaires Exclusion Criteria: \- none
Contact & Investigator
Marit Helen Andersen
PRINCIPAL INVESTIGATOR
Oslo University Hospital
Frequently Asked Questions
Who can join the NCT06379009 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Transplant; Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06379009 currently recruiting?
Yes, NCT06379009 is actively recruiting participants. Contact the research team at tomaro@ous-hf.no for enrollment information.
Where is the NCT06379009 trial being conducted?
This trial is being conducted at Oslo, Norway.
Who is sponsoring the NCT06379009 clinical trial?
NCT06379009 is sponsored by Oslo University Hospital. The principal investigator is Marit Helen Andersen at Oslo University Hospital. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.